Latest Board Changes News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

Dusk Group Limited has reported a solid 5.2% increase in net profit for the half year ended December 2025, alongside a 5.1% rise in revenue. The company also announced a fully franked interim dividend doubling the prior payout, signalling confidence in its retail operations.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

humm Group Limited has posted a statutory profit after tax of $13.9 million for the half-year ended 31 December 2025, marking a 49% decline from the previous year, driven by increased credit losses and legal costs. Despite challenges, the company declared a fully franked interim dividend of 1.5 cents per share.

SGH Ltd reported a solid half-year profit of $472.6 million, declaring a fully franked 32 cent dividend, while completing a major media merger that reshapes its investment portfolio.

A volatile week for ASX tech saw a steep sell-off in freight software, while defence AI and RegTech contract wins pulled buyers back into smaller names. Big corporate actions kept attention on what’s real: signed deals, cash timelines, and who pays whom, and when.

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.

Manhattan Gold Limited has reshaped its board and management team following the full acquisition of the Hook Lake Project, signalling a strategic pivot towards advancing this key asset.

Mamba Exploration Limited has agreed to acquire a 70% interest in the Meeka East Gold Project in Western Australia’s Murchison Goldfield, supported by a $2 million capital raise to fund exploration activities.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.